116 related articles for article (PubMed ID: 3237766)
1. An acid-independent antiulcer effect of M1 antimuscarinics in the rat.
Kromer W; Gönne S
Pharmacology; 1988; 37 Suppl 1():48-53. PubMed ID: 3237766
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the gastric antisecretory and antiulcer potencies of telenzepine, pirenzepine, ranitidine and cimetidine in the rat.
Riedel R; Bohnenkamp W; Eltze M; Heintze K; Prinz W; Kromer W
Digestion; 1988; 40(1):25-32. PubMed ID: 3234616
[TBL] [Abstract][Full Text] [Related]
3. Direct comparison between the ulcer-healing effects of two H(+)-K(+)-ATPase inhibitors, one M1-selective antimuscarinic and one H2 receptor antagonist in the rat.
Kromer W; Gönne S; Riedel R; Postius S
Pharmacology; 1990; 41(6):333-7. PubMed ID: 1982899
[TBL] [Abstract][Full Text] [Related]
4. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
Muramatsu M; Isobe Y; Arai I; Hirose-Kijima H; Usuki-Ito C; Nagai H; Aihara H; Otomo S
Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169
[TBL] [Abstract][Full Text] [Related]
5. Gastric antisecretory activity of telenzepine, a new M1-selective muscarinic antagonist: comparison with pirenzepine.
Coruzzi G; Adami M; Bertaccini G
Arch Int Pharmacodyn Ther; 1989; 302():232-41. PubMed ID: 2636819
[TBL] [Abstract][Full Text] [Related]
6. Telenzepine, a new M1-receptor antagonist, is a more potent inhibitor of pentagastrin-stimulated gastric acid output than pirenzepine in dogs.
Holtmann G; Küppers U; Singer MV
Scand J Gastroenterol; 1990 Mar; 25(3):293-7. PubMed ID: 2320949
[TBL] [Abstract][Full Text] [Related]
7. BAY P 1455, a thiazolylaminobenzimidazole derivative with gastroprotective properties in the rat.
Grassi A; Ippen J; Bruno M; Thomas G
Eur J Pharmacol; 1991 Mar; 195(2):251-9. PubMed ID: 1908386
[TBL] [Abstract][Full Text] [Related]
8. Antiulcer effects of 3-[[[2-(3,4-dimethoxyphenyl)ethyl] carbamoyl]methyl]-amino-N-methylbenzamide in experimental gastric and duodenal ulcers.
Asano M; Kurebayashi Y; Ryokawa Y; Hashizume T; Akashi A
Arzneimittelforschung; 1990 Mar; 40(3):276-81. PubMed ID: 2346535
[TBL] [Abstract][Full Text] [Related]
9. Comparison of telenzepine, pirenzepine and atropine on gastric acid and pepsin secretion in response to histamine, pentagastrin, bethanechol, sham-feeding and feeding.
Konturek SJ; Tasler J; Cieszkowski M; Szewczyk K; Kromer W
Digestion; 1989; 44(2):66-78. PubMed ID: 2575551
[TBL] [Abstract][Full Text] [Related]
10. Effect of antisecretory agents and vagotomy on healing of "chronic" cysteamine-induced duodenal ulcers in rats.
Poulsen SS; Raaberg L; Therkelsen K; Skov Olsen P; Kirkegaard P
Dig Dis Sci; 1986 Jul; 31(7):753-9. PubMed ID: 3720471
[TBL] [Abstract][Full Text] [Related]
11. Anti-ulcer and secretion-inhibitory properties of the tricyclic derivative doxepin in rats and dogs.
Leitold M; Fleissig W; Merk A
Arzneimittelforschung; 1984; 34(4):468-73. PubMed ID: 6547610
[TBL] [Abstract][Full Text] [Related]
12. 4-Methoxyphenyl 4-(3,4,5-trimethoxybenzyl)-1-piperazineacetate monofumarate monohydrate (KB-5492), a new anti-ulcer agent with a selective affinity for the sigma receptor, prevents cysteamine-induced duodenal ulcers in rats by a mechanism different from that of cimetidine.
Morimoto Y; Shimohara K; Tanaka K; Hara H; Sukamoto T
Jpn J Pharmacol; 1994 Mar; 64(3):221-4. PubMed ID: 8022123
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of the gastric antisecretory activity of histamine H2-receptor antagonists by clebopride.
Fernández AG; Massingham R; Roberts DJ
Methods Find Exp Clin Pharmacol; 1988 May; 10(5):285-93. PubMed ID: 2899659
[TBL] [Abstract][Full Text] [Related]
14. Pirenzepine prevents cysteamine-induced formation of gastroduodenal ulcers and reduction of mesenteric circulation.
Bernardini MC; Blandizzi C; Morini G; Chiavarini M; Impicciatore M; Del Tacca M
Arch Int Pharmacodyn Ther; 1989; 302():242-54. PubMed ID: 2636820
[TBL] [Abstract][Full Text] [Related]
15. Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine, and atropine effect in cysteamine lesions in totally gastrectromized rats: a model for cytoprotective studies.
Sikirić P; Mikus D; Seiwerth S; Grabarević Z; Rucman R; Petek M; Jagić V; Turković B; Rotkvić I; Mise S; Zoricić I; Perić J; Konjevoda P; Perović D; Jurina L; Hanzevacki M; Separović J; Gjurasin M; Jadrijević S; Jelovac N; Miklić P; Buljat G; Marović A
Dig Dis Sci; 1997 May; 42(5):1029-37. PubMed ID: 9149058
[TBL] [Abstract][Full Text] [Related]
16. Different effect of antiulcer agents on rat cysteamine-induced duodenal ulcer after sialoadenectomy, but not gastrectomy.
Bedekovic V; Mise S; Anic T; Staresinic M; Gjurasin M; Kopljar M; Kalogjera L; Drvis P; Boban Blagaic A; Batelja L; Seiwerth S; Sikiric P
Eur J Pharmacol; 2003 Sep; 477(1):73-80. PubMed ID: 14512101
[TBL] [Abstract][Full Text] [Related]
17. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
[TBL] [Abstract][Full Text] [Related]
18. Gastric and duodenal antiulcer and cytoprotective effects of proglumide in rats.
Tariq M; Parmar NS; Ageel AM
J Pharmacol Exp Ther; 1987 May; 241(2):602-7. PubMed ID: 3572816
[TBL] [Abstract][Full Text] [Related]
19. Effects of KW-5805, a new antiulcer agent, on experimental gastric and duodenal ulcers, gastric mucosal lesions by necrotizing agents and gastric acid secretion.
Kosaka N; Tanaka H; Tomaru A; Ishii A; Shuto K
Jpn J Pharmacol; 1994 Aug; 65(4):305-12. PubMed ID: 7990267
[TBL] [Abstract][Full Text] [Related]
20. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
